The statistical robustness of literature on extracorporeal shockwave therapy for the treatment of plantar fasciitis.
文献摘要
Background Extracorporeal shockwave therapy (ESWT) is widely used in the treatment of plantar fasciitis; however, the statistical robustness of randomized controlled trials (RCTs) supporting its use remains unclear. This study evaluates the fragility of dichotomous outcomes in RCTs on ESWT for plantar fasciitis using fragility index (FI) and fragility quotient (FQ) metrics. Methods A systematic search of PubMed and Scopus was conducted on March 1, 2025, to identify RCTs investigating ESWT for plantar fasciitis. Eligible studies included dichotomous outcomes in comparison to no treatment or alternative interventions. FI was calculated using two-tailed Fisher's exact tests. FQ was computed by dividing FI by the study's sample size. Subgroup analyses were conducted based on outcome type. Results Nineteen RCTs met inclusion criteria, yielding 159 dichotomous outcomes. Of these, 20 outcomes were statistically significant (p Conclusions Dichotomous outcomes in RCTs evaluating ESWT for plantar fasciitis demonstrate notable statistical fragility. Given that a small number of event reversals can shift the interpretation of many findings, clinicians should interpret statistically significant ESWT outcomes with caution. Future studies should incorporate fragility metrics to improve transparency and support more reliable clinical decision-making. Study type Systematic Review.